QC Technologies 2025 Q3 Earnings 97.7% Improvement in Loss per Share Amid Worsening Net Loss

Q/C Technologies (QCLS) reported mixed fiscal 2025 Q3 results on Nov 19th, 2025, with a 97.7% reduction in per-share loss but a 45.7% increase in net loss. The company’s rebranding from TNF Pharmaceuticals and acquisition of LPU Holdings LLC underscore its strategic pivot to energy-efficient blockchain and quantum-class computing. Despite operational restructuring, including facility lease termination, financial challenges persist, with no guidance provided for future performance.

Revenue

The total revenue of Q/C Technologies remained stable at $0 in 2025 Q3 with no significant change from 2024 Q3.

Earnings/Net Income

Q/C Technologies narrowed losses to $2.50 per share in 2025 Q3 from a loss of $107.62 per share in 2024 Q3 (97.7% improvement). Meanwhile, the company's net loss widened to $-2.81 million in 2025 Q3, representing a 45.7% increase from the $-1.93 million loss recorded in 2024 Q3. While the per-share loss narrowed significantly, the overall net loss expanded, highlighting ongoing financial challenges.

Price Action

The stock price of Q/C Technologies has climbed 5.88% during the latest trading day, has tumbled 8.22% during the most recent full trading week, and has plummeted 28.32% month-to-date. The strategy of buying Q/C Technologies (QCLS) shares on the date of release of its quarterly financial reports and holding for 30 days showed favorable performance over the past three years. The approach yielded a 24.37% return, compared to the 18.28% return of the NASDAQ Composite Index over the same period. This indicates that the strategy effectively captured the company's growth potential and market sentiment following its earnings releases.

CEO Commentary

Strategic Rebranding and Operational Shifts

Q/C Technologies’ CEO emphasized the company’s transition from pharmaceuticals to energy-efficient blockchain and quantum-class computing, citing the acquisition of LPU Holdings LLC as a pivotal step. The rebranding to Q/C Technologies reflects a commitment to leveraging LightSolver’s global licensing agreement for LPUs. Despite a 45.7% increase in net loss, the CEO highlighted confidence in current financial resources to sustain operations for the next twelve months.

Guidance

No explicit forward-looking guidance was provided in the Q3 2025 earnings report or accompanying SEC filings. The company’s focus remains on operational restructuring and strategic acquisitions to align with its new business direction, though no quantitative targets for future performance were outlined.

Additional News

Q/C Technologies, Inc. disclosed in its SEC 10-Q filing a strategic rebranding and acquisition of LPU Holdings LLC on September 2, 2025, to expand high-performance computing capabilities. The company terminated its Baltimore facility lease as part of operational restructuring. Additionally, stockholders approved a merger to reincorporate from New Jersey to Delaware, streamlining governance. While the company shifted focus from pharmaceuticals to quantum-class laser-based computing, it continues developing Isomyosamine and Supera-CBD therapeutic platforms.